Goldman Sachs
IMNN icon

Goldman Sachs’s Imunon IMNN Stock Holding History

Goldman Sachs’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-186
Closed -$2.65M – 6718
2013
Q3 		$2.65M Buy
+186
New +$2.75M ﹤0.01% 3645

Other funds holding IMNN

ACM
Altium Capital Management New York $42M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EP
Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs's IMNN Position: Q1 2021 in Review

Goldman Sachs sold out of Imunon (IMNN) in Q1 2021, closing a stake of 62 shares — an estimated $9K sold.

Goldman Sachs first reported a position in IMNN in Q2 2013 and held it in 9 quarters. The position peaked at $328K in Q4 2014. 40 funds tracked by Wall St. Rank hold IMNN as of Q1 2021.

  • Goldman Sachs reported no remaining Imunon position as of Q1 2021 after selling out during the quarter.
  • Goldman Sachs sold 62 Imunon shares in Q1 2021, an estimated $9K.
  • Goldman Sachs first reported a position in Imunon in Q2 2013 and held it in 9 quarters.
  • Goldman Sachs's Imunon position peaked at $328K in Q4 2014.
  • 40 funds tracked by Wall St. Rank held Imunon as of Q1 2021.

Based on Goldman Sachs's 13F filing for Q1 2021, filed 17 May 2021.